These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7813417)

  • 1. Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis.
    Van Parys JA; Meinardi H
    Epilepsy Res; 1994 Sep; 19(1):79-85. PubMed ID: 7813417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment.
    Friis ML; Kristensen O; Boas J; Dalby M; Deth SH; Gram L; Mikkelsen M; Pedersen B; Sabers A; Worm-Petersen J
    Acta Neurol Scand; 1993 Mar; 87(3):224-7. PubMed ID: 8475694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spotlight on oxcarbazepine in epilepsy.
    Bang LM; Goa KL
    CNS Drugs; 2004; 18(1):57-61. PubMed ID: 14731060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine for epilepsy--a useful new choice?
    Drug Ther Bull; 2002 Jun; 40(6):46-8. PubMed ID: 12143266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical aspects of oxcarbazepine treatment.
    Dam M
    Epilepsia; 1994; 35 Suppl 3():S23-5. PubMed ID: 8156977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of efficacy of trileptal (oxcarbazepine) and carbamazepine in the treatment of temporal epilepsy].
    Sokolova LV; Kalinin VV; Zheleznova EV; Zemlianaia AA; Polianskiĭ DA; Basamygin AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 2():63-7. PubMed ID: 19431253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxcarbazepine in the treatment of early childhood epilepsy.
    Gaily E; Granström ML; Liukkonen E
    J Child Neurol; 1997 Nov; 12(8):496-8. PubMed ID: 9430314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyponatremia induced by oxcarbazepine in children.
    Borusiak P; Korn-Merker E; Holert N; Boenigk HE
    Epilepsy Res; 1998 May; 30(3):241-6. PubMed ID: 9657651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxcarbazepine in the treatment of epilepsy in children and adolescents with intellectual disability.
    Gaily E; Granström ML; Liukkonen E
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():41-5. PubMed ID: 10030431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oxcarbazepine in the treatment of epilepsy].
    Freidel M; Krause E; Kuhn K; Peper R; Vogel H
    Fortschr Neurol Psychiatr; 2007 Feb; 75(2):100-6. PubMed ID: 17200915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical development outlook of oxcarbazepine.
    Schwabe S
    Epilepsia; 1994; 35 Suppl 3():S2-4. PubMed ID: 8156975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxcarbazepine.
    Beydoun A; Kutluay E
    Expert Opin Pharmacother; 2002 Jan; 3(1):59-71. PubMed ID: 11772334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of oxcarbazepine and carbamazepine: a double-blind study.
    Reinikainen KJ; Keränen T; Halonen T; Komulainen H; Riekkinen PJ
    Epilepsy Res; 1987 Sep; 1(5):284-9. PubMed ID: 3504404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of the monotherapy with trileptal (oxcarbazepine) in children and adolescents].
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Suppl 1):45-50. PubMed ID: 20559267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
    Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyponatraemia during oxcarbazepine therapy.
    Pendlebury SC; Moses DK; Eadie MJ
    Hum Toxicol; 1989 Sep; 8(5):337-44. PubMed ID: 2680897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy.
    Rey E; Bulteau C; Motte J; Tran A; Sturm Y; D'Souza J; Markabi S; Pons G; Dulac O
    J Clin Pharmacol; 2004 Nov; 44(11):1290-300. PubMed ID: 15496647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.